| Authors: |
Sasaki K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rausch CR; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Goulart H; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jain N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Huang X; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hachem M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wierda WG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia TM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Alvarado Y; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garris R; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour E; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
